×
About 56,178 results

ALLMedicine™ Melanoma Center

Research & Reviews  20,139 results

Annual Report to the Nation: Rapid Decrease in Lung Cancer and Melanoma Deaths Lead Overall Continued Decline in Cancer Death Rate
http://pressroom.cancer.org/ARN2021
American Cancer Society

Jul 8th, 2021 - Overall cancer death rates continue to decline in men and women for all racial and ethnic groups in the United States, according to the latest Annual Report to the Nation on the Status of Cancer. During 2001 to 2018, declines in lung cancer death ...

Assessing the Prognostic Significance of Tumor-Infiltrating Lymphocytes in Patients Wit...
https://doi.org/10.1001/jamanetworkopen.2021.26337
JAMA Network Open; Yang J, Lian JW et. al.

Sep 23rd, 2021 - Although tumor-infiltrating lymphocytes (TILs) are an important histopathologic characteristic reflecting host immune response in patients with melanoma, their prognostic value remains controversial. Because manual review of medical records is lab...

The mucin protein MUCL1 regulates melanogenesis and melanoma genes in a manner dependen...
https://doi.org/10.1111/bjd.20761
The British Journal of Dermatology; Kim J, Choi H

Sep 22nd, 2021 - The regulation of melanogenesis has been investigated as a long-held aim for pharmaceutical manipulations with denotations for malignancy of melanoma. Mucins have protective function in epithelial organs however, the most outer organ, skin, the ro...

Tumor reactivity of CD8+ T cells favors acquisition of dysfunctional states in human me...
https://doi.org/10.1111/imcb.12498
Immunology and Cell Biology; Hochheiser K, Gyorki DE et. al.

Sep 22nd, 2021 - A recent study by Oliveira et al. provides, in unprecedented detail, novel insights into the relationship between tumorreactivity and functional states of CD8 T cells in metastatic melanoma.

see more →

Guidelines  32 results

Annual Report to the Nation: Rapid Decrease in Lung Cancer and Melanoma Deaths Lead Overall Continued Decline in Cancer Death Rate
http://pressroom.cancer.org/ARN2021
American Cancer Society

Jul 8th, 2021 - Overall cancer death rates continue to decline in men and women for all racial and ethnic groups in the United States, according to the latest Annual Report to the Nation on the Status of Cancer. During 2001 to 2018, declines in lung cancer death ...

SEOM clinical guideline for the management of cutaneous melanoma (2020).
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057998
Clinical & Translational Oncology : Official Publication ... Majem M, Manzano JL et. al.

Mar 3rd, 2021 - Melanoma affects about 6000 patients a year in Spain. A group of medical oncologists from Spanish Society of Medical Oncology (SEOM) and Spanish Multidisciplinary Melanoma Group (GEM) has designed these guidelines to homogenize the management of t...

Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice r...
https://doi.org/10.1007/s00520-020-05709-1
Supportive Care in Cancer : Official Journal of the Multi... Cooksley T, Girotra M et. al.

Aug 29th, 2020 - Immune checkpoint inhibitors (ICIs) have emerged as the newest pillar of cancer treatment, transforming outcomes in melanoma and showing benefit in a range of malignancies. Immune-mediated toxicities, stemming from increased activity within the T ...

ESMO consensus conference recommendations on the management of locoregional melanoma: u...
https://doi.org/10.1016/j.annonc.2020.07.005
Annals of Oncology : Official Journal of the European Soc... Michielin O, van Akkooi A et. al.

Aug 9th, 2020 - The European Society for Medical Oncology (ESMO) held a consensus conference on melanoma on 5-7 September 2019 in Amsterdam, The Netherlands. The conference included a multidisciplinary panel of 32 leading experts in the management of melanoma. Th...

ESMO consensus conference recommendations on the management of metastatic melanoma: und...
https://doi.org/10.1016/j.annonc.2020.07.004
Annals of Oncology : Official Journal of the European Soc... Keilholz U, Ascierto PA et. al.

Aug 9th, 2020 - The European Society for Medical Oncology (ESMO) held a consensus conference on melanoma on 5-7 September 2019 in Amsterdam, The Netherlands. The conference included a multidisciplinary panel of 32 leading experts in the management of melanoma. Th...

see more →

Drugs  43 results see all →

Clinicaltrials.gov  3 results

Annual Report to the Nation: Rapid Decrease in Lung Cancer and Melanoma Deaths Lead Overall Continued Decline in Cancer Death Rate
http://pressroom.cancer.org/ARN2021
American Cancer Society

Jul 8th, 2021 - Overall cancer death rates continue to decline in men and women for all racial and ethnic groups in the United States, according to the latest Annual Report to the Nation on the Status of Cancer. During 2001 to 2018, declines in lung cancer death ...

Ibrutinib in Treating Patients With Refractory Stage IV Cutaneous Melanoma
https://clinicaltrials.gov/ct2/show/NCT03427398

Jan 31st, 2018 - PRIMARY OBJECTIVES: I. Estimate rate of objective response (OR: complete response [CR] + partial response [PR]) to ibrutinib administered as single agent in patients with immune checkpoint inhibitor-refractory and mitogen-activated protein kinase ...

Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma Patients
https://clinicaltrials.gov/ct2/show/NCT01867619

Jun 4th, 2013 - The dosages of Temozolomide and Thalidomide will be fixed, and the dose of Lomustine will be the phase I MTD or the highest dose studied if the MTD was not attained. All 3 drugs will be taken by mouth at home. Each treatment cycle will last for 8 ...

see more →

News  2,245 results

Annual Report to the Nation: Rapid Decrease in Lung Cancer and Melanoma Deaths Lead Overall Continued Decline in Cancer Death Rate
http://pressroom.cancer.org/ARN2021
American Cancer Society

Jul 8th, 2021 - Overall cancer death rates continue to decline in men and women for all racial and ethnic groups in the United States, according to the latest Annual Report to the Nation on the Status of Cancer. During 2001 to 2018, declines in lung cancer death ...

Recent Trend: Melanoma Mortality Declining Rapidly
https://www.medscape.com/viewarticle/955112

Jul 20th, 2021 - Declining trends in melanoma death rates accelerated from 2014 to 2018 in the United States, even as incidence rates increased for both males and females, according to an annual report by several national organizations. "Death rates for cutaneous ...

Johnson & Johnson Consumer Inc. Issues Voluntary Recall of Specific NEUTROGENA® and AVEENO® Aerosol Sunscreen Products Due to the Presence of Benzene | FDA
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/johnson-johnson-consumer-inc-issues-voluntary-recall-specific-neutrogenar-and-aveenor-aerosol

Summary Company Announcement Date: July 14, 2021 FDA Publish Date: July 14, 2021 Product Type: Drugs Reason for Announcement: Recall Reason Description Testing identified low levels of benzene Company Name: Johnson & Johnson Brand Name: Brand Name...

NSCLC and Melanoma Lead Continuing Fall in US Cancer Death Rates
https://www.medscape.com/viewarticle/954760

Jul 14th, 2021 - Cancer death rates in the United States continue to decline overall for many common cancers. This decline is particularly prounounced for non–small cell lung cancer (NSCLC) and melanoma, according to the latest statistics in the "Annual Report to ...

Latest FDA Pembrolizumab Approval Expands Label to Cutaneous SCCs
https://www.medscape.com/viewarticle/954715

Jul 13th, 2021 - The Food and Drug Administration has approved pembrolizumab (Keytruda) monotherapy for locally advanced cutaneous squamous cell carcinoma (cSCC) that can't be cured by surgery or radiation. The July 6 approval for the programmed death–1 inhibitor ...

see more →

Patient Education  9 results see all →